Company Valuation: Pacira BioSciences, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,890 2,600 2,680 1,772 1,567 1,205 1,205 -
Change - 37.52% 3.1% -33.9% -11.56% -23.08% 0% -
Enterprise Value (EV) 1 2,118 2,962 3,144 2,357 1,811 1,309 1,188 943
Change - 39.85% 6.13% -25.03% -23.17% -27.73% -9.19% -20.64%
P/E ratio -168x 18x 65.4x 114x 37.9x -12.9x 13.5x 8.06x
PBR 5.35x 4.21x 3.69x 2.29x - 1.47x 1.36x 1.17x
PEG - -0x -0.9x -1.8x 0x 0x -0x 0.1x
Capitalization / Revenue 4.49x 6.05x 4.95x 2.66x 2.32x 1.72x 1.63x 1.59x
EV / Revenue 5.03x 6.89x 5.81x 3.53x 2.68x 1.87x 1.6x 1.25x
EV / EBITDA 22.3x 26.3x 15.4x 11.1x 8.44x 5.95x 5.19x 3.1x
EV / EBIT 28.1x 29.8x 16.6x 12.1x 9.16x 6.5x 5.36x 3.96x
EV / FCF 30.5x 40.6x 39.4x 20.5x 13x 9.23x 6.92x 5.59x
FCF Yield 3.28% 2.47% 2.54% 4.89% 7.7% 10.8% 14.5% 17.9%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.27 3.33 0.92 0.34 0.89 -2.017 1.93 3.237
Distribution rate - - - - - - - -
Net sales 1 421 429.6 541.5 666.8 675 699.9 740.5 756.5
EBITDA 1 94.86 112.6 204 212.7 214.5 220 229 304.2
EBIT 1 75.28 99.3 189.2 194.8 197.7 201.4 221.8 237.9
Net income 1 -11.02 145.5 41.98 15.91 41.96 -18.02 66.35 83.1
Net Debt 1 227.8 362.7 463.7 585.3 243.9 103.4 -16.87 -262.2
Reference price 2 45.30 59.84 60.17 38.61 33.74 26.10 26.10 26.10
Nbr of stocks (in thousands) 41,731 43,444 44,544 45,882 46,438 46,173 46,173 -
Announcement Date 2/20/20 2/25/21 2/24/22 2/28/23 2/29/24 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio (N) EV / Sales (N) EV / EBITDA (N) Yield (N) Capi.($)
-12.94x1.87x5.95x - 1.21B
70.58x17.84x49.86x0.6% 782B
22.44x7.93x15.45x2.25% 378B
22.27x4.31x12.58x3.09% 371B
43.21x7.05x16.25x3.27% 336B
15.4x3.76x9.3x3.42% 256B
27.23x4.64x14.65x2.14% 225B
16.62x4.18x10.11x3.57% 210B
32.28x6.26x11x3.06% 158B
15.2x3.25x8.19x6.44% 147B
Average 25.23x 6.11x 15.33x percentage-no-prefix 286.56B
Weighted average by Cap. 37.48x 8.82x 22.94x percentage-no-prefix
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. PCRX Stock
  4. Valuation Pacira BioSciences, Inc.